409OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. (23rd October 2018) - Lassen, U N; Albert, C M; Kummar, S; van Tilburg, C M; Dubois, S G; Geoerger, B; Mascarenhas, L; Federman, N; Schilder, R J; Doz, F; Berlin, J D; Oh, D-Y; et al.